Moderna, Inc. — Director's Dealing 2020

Aug 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-08-24

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-24	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2020-08-24	Common Stock	M	5000	$12.21	Acquired	15000	Direct
2020-08-24	Common Stock	M	10000	$19.15	Acquired	25000	Direct
2020-08-24	Common Stock	S	3303	$63.65	Disposed	21697	Direct
2020-08-24	Common Stock	S	9849	$64.56	Disposed	11848	Direct
2020-08-24	Common Stock	S	8690	$65.35	Disposed	3158	Direct
2020-08-24	Common Stock	S	2058	$66.40	Disposed	1100	Direct
2020-08-24	Common Stock	S	1100	$67.31	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-24	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2020-08-24	Stock Option (Right to Buy)	$12.21	M	5000	Disposed	2027-02-23	Common Stock (5000)	Direct
2020-08-24	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.98 to $63.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.01 to $65.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.02 to $66.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.04 to $66.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.15 to $67.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.

F8: This option is fully vested and exercisable.